Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.84%10.91B | -1.86%52.65B | 2.49%12.96B | 1.25%53.65B | -10.40%13.34B | 2.88%13.87B | -2.18%13.79B | 20.29%12.64B | 11.84%52.99B | 18.70%14.89B |
| Cost of revenue | -15.70%9.04B | -1.72%43.99B | 2.26%10.73B | -3.82%44.77B | -16.12%11.44B | -0.55%11.56B | -8.47%11.28B | 17.03%10.49B | 17.60%46.55B | 27.43%13.64B |
| Gross profit | -16.55%1.86B | -2.54%8.66B | 3.59%2.23B | 37.96%8.88B | 51.86%1.9B | 24.24%2.31B | 41.50%2.51B | 39.14%2.16B | -17.40%6.44B | -32.01%1.25B |
| Operating expense | 8.02%1.99B | 8.36%7.67B | 7.29%1.84B | 6.12%7.08B | 13.30%1.94B | 4.20%1.74B | 1.22%1.67B | 5.55%1.72B | 1.53%6.67B | 2.04%1.71B |
| Operating profit | -133.28%-129.26M | -45.23%990.01M | -10.96%388.4M | 890.53%1.81B | 92.00%-36.7M | 201.06%570.96M | 594.63%837.1M | 646.02%436.21M | -118.62%-228.65M | -377.77%-458.93M |
| Net non-operating interest income (expenses) | -71.51%-30.29M | -35.47%-84.32M | -9.53%-17.66M | -9.14%-62.24M | -10.61%-16.9M | -16.08%-15.82M | 7.83%-13.4M | -18.69%-16.12M | -22.61%-57.03M | -16.91%-15.28M |
| Non-operating interest income | 14.92%1.3M | -7.69%8.48M | -17.48%1.13M | 38.60%9.19M | 43.77%3.75M | -3.25%1.28M | 43.65%2.78M | 80.90%1.37M | -19.32%6.63M | 75.34%2.61M |
| Non-operating interest expense | 68.09%31.59M | 29.91%92.8M | 7.41%18.79M | 12.21%71.43M | 15.45%20.65M | 14.37%17.1M | -1.77%16.19M | 21.98%17.5M | 16.31%63.66M | 22.88%17.89M |
| Net investment income | 66.17%357.7M | 29.02%254.32M | 23.42%215.26M | 5.97%197.11M | -765K | -7.18%17.62M | 2.18%5.85M | 8.13%174.41M | -7.06%186M | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 306.11M | -100.07%-59K | 0 | 11.93%84.54M | -112.17%-9.2M | 0 | 0 | 93.73M | 63.88%75.53M | 164.03%75.53M |
| Income from associates and other participating interests | 44.82%86.28M | 10.46%285.58M | -16.61%59.57M | 57.79%258.55M | 69.75%89M | 38.18%48.6M | 17.76%49.52M | 108.83%71.44M | -25.00%163.86M | 23.03%52.43M |
| Special income (charges) | -97.46%216K | -2,805.97%-638.66M | 128.38%8.52M | -65.19%23.6M | -10.42%70.74M | -262.93%-12.07M | -94.99%-5.06M | -471.38%-30.01M | -61.61%67.79M | 134.96%78.97M |
| Less:Other special charges | 97.46%-216K | -163.66%-62.23M | -128.38%-8.52M | 65.19%-23.6M | 10.42%-70.74M | 262.93%12.07M | 94.99%5.06M | 471.38%30.01M | 6.16%-67.79M | -2.90%-78.97M |
| Less:Write off | ---- | --700.89M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 2.00%37.03M | -82.75%-55.88M | 231.82%36.3M | 38.50%-30.58M | 92.44%-6.56M | 87.41%-8.95M | -76.71%12.47M | -150.47%-27.54M | 55.81%-49.73M | 46.15%-86.73M |
| Income before tax | -9.07%627.79M | -67.04%751M | -1.67%690.4M | 1,344.24%2.28B | 125.31%89.62M | 285.50%600.34M | 333.05%886.48M | 363.90%702.12M | -90.78%157.77M | -14.64%-354.02M |
| Income tax | 4.75%342.02M | -50.71%742.79M | 0.25%326.52M | 206.32%1.51B | 978.59%429.53M | 95.93%410.06M | 192.34%341.74M | 158.57%325.7M | -34.84%491.97M | -34.99%39.82M |
| Net income | -21.47%285.77M | -98.94%8.21M | -3.33%363.88M | 330.85%771.51M | 13.69%-339.91M | 455.26%190.27M | 520.39%544.74M | 1,382.76%376.41M | -134.98%-334.21M | -6.42%-393.84M |
| Net income continuous operations | -21.47%285.77M | -98.94%8.21M | -3.33%363.88M | 330.85%771.51M | 13.69%-339.91M | 455.26%190.27M | 520.40%544.74M | 1,382.70%376.41M | -134.98%-334.21M | -6.42%-393.84M |
| Noncontrolling interests | -35.18%31.67M | 38.62%217.96M | 53.28%48.85M | 49.77%157.24M | 39.90%-15.84M | -10.56%60.53M | 63.05%80.68M | 124.63%31.87M | 32.87%104.99M | 53.13%-26.36M |
| Net income attributable to the company | -19.34%254.1M | -134.15%-209.75M | -8.57%315.02M | 239.86%614.27M | 11.81%-324.07M | 207.01%129.74M | 1,110.97%464.05M | 2,976.83%344.54M | -150.12%-439.2M | -17.10%-367.48M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.34%254.1M | -134.15%-209.75M | -8.57%315.02M | 239.86%614.27M | 11.81%-324.07M | 207.01%129.74M | 1,110.97%464.05M | 2,976.83%344.54M | -150.12%-439.2M | -17.10%-367.48M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.31%4.68 | -134.13%-3.86 | -8.66%5.8 | 240.15%11.31 | 11.56%-5.97 | 207.17%2.39 | 1,102.82%8.54 | 3,075.00%6.35 | -151.63%-8.07 | -22.28%-6.75 |
| Diluted earnings per share | -19.31%4.68 | -134.13%-3.86 | -8.66%5.8 | 240.15%11.31 | 11.80%-5.97 | 207.15%2.3895 | 1,118.09%8.54 | 3,075.00%6.35 | -151.63%-8.07 | -18.91%-6.7683 |
| Dividend per share | 0 | 0.00%13 | 0 | 13 | 6.5 | 0 | 6.5 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |